作者：
Dragana,Milaković [1]
;
Tijana,Kovačević [2]
;
Pedja,Kovačević [3]
;
Vedrana,Barišić [3]
;
Sanja,Avram [4]
;
Saša,Dragić [2]
;
Biljana,Zlojutro [5]
;
Danica,Momčičević [3]
;
Branislava,Miljković [4]
;
Katarina,Vučićević [3]
作者单位：
Department of Nuclear Medicine and Thyroid Gland Diseases, University Clinical Centre of the Republic of Srpska, 78000 Banja Luka, Bosnia and Herzegovina.
[1]
Pharmacy Department, University Clinical Centre of the Republic of Srpska, 78000 Banja Luka, Bosnia and Herzegovina.
[2]
Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina.
[3]
Medical Intensive Care Unit, University Clinical Centre of the Republic of Srpska, 78000 Banja Luka, Bosnia and Herzegovina.
[4]
Institute of Laboratory Diagnostic, University Clinical Centre of the Republic of Srpska, 78000 Banja Luka, Bosnia and Herzegovina.
[5]
Department of Pharmacokinetics and Clinical Pharmacy, University of Belgrade-Faculty of Pharmacy, 11221 Belgrade, Serbia.
[6]
DOI
10.3390/pharmaceutics16020253
PMID
38399307
发布时间
2024-02-27
换一批
换一批
